<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TAMSULOSIN HYDROCHLORIDE</span><br/>(tam'su-lo-sin)<br/><span class="topboxtradename">Flomax<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">alpha-adrenergic antagonist (sympatholytic agent)</span><br/><b>Prototype: </b>Prazosin HCl<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.4 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Antagonist of the alpha<sub>1A</sub>-adrenergic receptors located in the prostate. Symptoms related to benign prostatic hypertrophy (BPH) are related to bladder
         outlet obstruction.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Blockage of alpha<sub>1A</sub>-adrenergic receptors can cause smooth muscles in the bladder outlet and the prostate gland to relax, resulting in improvement
         in urinary blood flow and a reduction in symptoms of BPH. Indicated by improved voiding.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Benign prostatic hypertrophy.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to tamsulosin; in conjunction with another alpha<sub>1A</sub>-adrenergic blocking agent; lactation, pediatric patients.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category B); history of syncope, hypotension.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Benign Prostatic Hypertrophy</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 0.4 mg q.d. 30 min after a meal, may increase up to 0.8 mg q.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give 30 min after the same meal each day.</li>
<li>Instruct to swallow capsules whole; not to crush, chew, or open.</li>
<li>If dose is interrupted for several days, reinitiate at the lowest dose, 0.4 mg.</li>
<li>Store at 20°25° C (68°77° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Asthenia, back or chest pain. <span class="typehead">CNS:</span>
<span class="speceff-common">Headache, dizziness,</span> insomnia. <span class="typehead">CV:</span>
<span class="speceff-common">Orthostatic hypotension (especially with first dose)</span>. <span class="typehead">GI:</span> Diarrhea, nausea. <span class="typehead">Respiratory:</span>
<span class="speceff-common">Rhinitis,</span> pharyngitis, increased cough, sinusitis. <span class="typehead">Urogenital:</span> Decreased libido, <span class="speceff-common">abnormal ejaculation</span>. <span class="typehead">Special Senses:</span> Amblyopia. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Cimetidine</b> may decrease clearance of tamsulosin. 
      				<b>Sildenafil,</b>
<b>vardenafil,</b> and <b>tadalafil</b> may enhance hypotensive effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract. &gt;90% bioavailability. <span class="typehead">Peak:</span> 45 h fasting, 67 h fed. <span class="typehead">Distribution:</span> Widely distributed in body tissues, including kidney and prostate. <span class="typehead">Metabolism:</span> Metabolized in the liver. <span class="typehead">Elimination:</span> 76% excreted in urine. <span class="typehead">Half-Life:</span> 1415 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for signs of orthostatic hypotension; take BP lying down, then upon standing. Report a systolic pressure drop of <img src="../images/special/greaterorequal.gif"/>15 mm Hg or a HR <img src="../images/special/greaterorequal.gif"/>15 beats upon
            standing.
         </li>
<li>Monitor patients on warfarin therapy closely.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Make position changes slowly to minimize orthostatic hypotension.</li>
<li>Report dizziness, vertigo, or fainting to physician. Exercise caution with hazardous activities until response to drug is
            known.
         </li>
<li>Be aware that concurrent use of cimetidine may increase the orthostatic hypotension adverse effect.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>